ArticleJournal of thrombosis and thrombolysis2023

Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions.

Fan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.